NeuroSense Therapeutics Ltd. stock is up 57.41% since 30 days ago. The next earnings date is Mar 20, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 2 February’s closed higher than January.
NeuroSense Therapeutics Ltd. focuses on discovering and developing treatments for debilitating neurodegenerative diseases in Israel. Its lead product candidate is PrimeC, a novel oral formulation for the treatment of amyotrophic lateral sclerosis.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!